In a recent research, we reported the identification and the characterization of a whole new atypical opioid receptor with exceptional adverse regulatory Houses in the direction of opioid peptides.1 Our benefits showed that ACKR3/CXCR7, hitherto often called an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is additionally a broad-sp